Clincosm LogoSign in Get a demo

biliary tract cancer

Showing 1 - 25 of 152
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

LIver, Biliary tRAct and pancReatic Cancers

Recruiting
  • Liver Cancer
  • +2 more
  • Blood drawing
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital, Zhejiang University School of Me
Nov 14, 2023

Biliary Tract Cancer Trial in Worldwide (Rilvegostomig, Placebo, Capecitabine)

Not yet recruiting
  • Biliary Tract Cancer
  • Clayton, Australia
  • +65 more
Oct 26, 2023

Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)

Not yet recruiting
  • Adult Soft Tissue Sarcoma
  • +4 more
  • Ezabenlimab + BI907828
  • Bordeaux, France
  • +5 more
Oct 19, 2023

Biliary Tract Cancer, Immune Checkpoint Inhibitor, Predictive Cancer Model Trial in Beijing (Immune Checkpoint Inhibitors)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Immune Checkpoint Inhibitors
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Oct 5, 2023

Biliary Tract Cancer, Cholangiocarcinoma Trial in Italy (Gemcitabine, Nab paclitaxel, Cisplatin)

Not yet recruiting
  • Biliary Tract Cancer
  • Cholangiocarcinoma
  • Ancona, Italy
  • +18 more
Sep 16, 2023

Borderline Resectable Carcinoma, Biliary Tract Cancer Trial in Washington (Durvalumab, Tremelimumab, Gemcitabine)

Not yet recruiting
  • Borderline Resectable Carcinoma
  • Biliary Tract Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

Biliary Tract Cancer Trial (GEN-001, Pembrolizumab, mFOLFOX)

Not yet recruiting
  • Biliary Tract Cancer
  • (no location specified)
Aug 16, 2023

Biliary Tract Cancer, Candonilimab, Claudin 18.2 Trial in Shanghai (cardonilizumab, LM-302)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Shanghai, China
    Zhongshan hospital, Fudan University
Aug 12, 2023

Observational Monocentric Study on Biliary Tract Cancer (BABEL)

Recruiting
  • Biliary Tract Cancer
    • Roma, Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli/IRCSS - UO
    Jul 10, 2023

    Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance Study -

    Not yet recruiting
    • Biliary Tract Cancer
      • (no location specified)
      Apr 26, 2023

      Hepatocellular Carcinoma, Biliary Tract Cancer Trial in Worldwide (MEDI5752, Bevacizumab, Lenvatinib)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • Biliary Tract Cancer
      • Birmingham, Alabama
      • +44 more
      Mar 17, 2023

      Biliary Tract Cancer Trial in Worldwide (Durvalumab, Gemcitabine monotherapy, Gemcitabine + cisplatin)

      Not yet recruiting
      • Biliary Tract Cancer
      • Durvalumab
      • +7 more
      • Orange, California
      • +36 more
      Mar 6, 2023

      Postoperative Recurrence in Biliary Tract Cancers:A Multicenter

      Recruiting
      • Biliary Tract Cancer
      • No intervention
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital with NanJing Medical University
      Feb 15, 2023

      European Training Program for Robotic Liver Surgery (LIVEROBOT)

      Not yet recruiting
      • Liver Diseases
      • +6 more
      • European Multicentre Training Program for Robotic Liver Surgery
      • (no location specified)
      Feb 8, 2023

      Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)

      Not yet recruiting
      • Pancreatic Cancer
      • +3 more
      • Durvalumab
      • +5 more
      • Edmonton, Alberta, Canada
        Cross Cancer Institute
      Feb 1, 2023

      Carcinoma, Hepatocellular, Biliary Tract Cancer, Secondary Liver Cancer Trial in Worldwide (RO7119929, Tocilizumab)

      Completed
      • Carcinoma, Hepatocellular
      • +3 more
      • Duarte, California
      • +9 more
      Jan 27, 2023

      Multi-Platform Profiling of Resected Biliary Tract Cancer

      Recruiting
      • Biliary Tract Cancer
      • +7 more
      • Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
      • Chicago, Illinois
      • +1 more
      Jan 23, 2023

      AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary

      Recruiting
      • Biliary Tract Cancer
      • Blood drawing
      • Guangzhou, Guangdong, China
      • +1 more
      Dec 28, 2022

      Biliary Tract Cancer Trial in Kaohsiung, Taichung (D07001-softgel capsules + Xeloda (or TS-1), mFOLFOX)

      Recruiting
      • Biliary Tract Cancer
      • D07001-softgel capsules + Xeloda (or TS-1)
      • mFOLFOX
      • Kaohsiung, Taiwan
      • +4 more
      Dec 22, 2022

      Biliary Tract Cancer Trial in Worldwide (Atezolizumab, Bevacizumab, Placebo)

      Active, not recruiting
      • Biliary Tract Cancer
      • Duarte, California
      • +49 more
      Dec 21, 2022

      Biliary Tract Cancer Trial in Boston, Ann Arbor, Nashville (Rucaparib, Nivolumab)

      Active, not recruiting
      • Biliary Tract Cancer
      • Boston, Massachusetts
      • +2 more
      Dec 6, 2022

      Biliary Tract Cancer Trial in Montréal (Tumour and germline molecular profiling)

      Recruiting
      • Biliary Tract Cancer
      • Tumour and germline molecular profiling
      • Montréal, Quebec, Canada
        McGill University Health Centre
      Nov 2, 2022

      Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

      Recruiting
      • Advanced Solid Tumor
      • +24 more
      • MDNA11 Monotherapy
      • MDNA11 in combination with checkpoint inhibitor
      • Santa Monica, California
      • +7 more
      Nov 1, 2022

      Pancreas Cancer, Biliary Tract Cancer, Psychological Distress Trial (Psilocybin)

      Not yet recruiting
      • Pancreas Cancer
      • +2 more
      • (no location specified)
      Oct 31, 2022

      Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seongnam-si (nab-paclitaxel plus gemcitabine-cisplatin)

      Recruiting
      • Biliary Tract Cancer
      • +2 more
      • nab-paclitaxel plus gemcitabine-cisplatin
      • Seongnam-si, Gyeonggi-do, Korea, Republic of
        CHA Bundang Medical Center
      Oct 27, 2022